Free Trial Information
BioCentury | Mar 15, 2018
Tools & Techniques

Shared burden

...NASDAQ:ILMN) (A) TruSight Tumor 170 Assay profiling mutations in tumor tissue using a 170-gene panel KEW Group Inc....
Read More
BioCentury | Jan 19, 2015
Financial News

KEW completes venture financing

KEW Group Inc. , Cambridge, Mass. Business: Diagnostic Date completed: 2015-01-12 Type: Venture financing Raised: $16.8 million Investors: Signet Healthcare Partners; Amzak Capital Management LLC; Arsenal Capital Management; Boylston Street Group WIR Staff...
Read More
BioCentury | Nov 4, 2013
Company News

KEW sales and marketing update

...genetic changes in tumors. The company said the test, which was developed and validated in KEW's...
...examine the genetic profile of many common cancers. KEW could not be reached for details. KEW Group Inc....
Read More
BioCentury | Aug 9, 2010
Clinical News

Abraxane nab-paclitaxel regulatory update

...treat metastatic breast cancer after failure of anthracycline therapy. Specialised Therapeutics Australia Pty. Ltd. (East Kew...
Read More
BioCentury | Jul 6, 1999
Company News

EcoScience, Rochester Consulting Group sales and marketing update

...of infecting and killing termites. EcoScience Corp. (ECSCE), East Brunswick, N.J. Rochester Consulting Group , Kew...
Read More
Items per page:
1 - 5 of 5
BioCentury | Mar 15, 2018
Tools & Techniques

Shared burden

...NASDAQ:ILMN) (A) TruSight Tumor 170 Assay profiling mutations in tumor tissue using a 170-gene panel KEW Group Inc....
Read More
BioCentury | Jan 19, 2015
Financial News

KEW completes venture financing

KEW Group Inc. , Cambridge, Mass. Business: Diagnostic Date completed: 2015-01-12 Type: Venture financing Raised: $16.8 million Investors: Signet Healthcare Partners; Amzak Capital Management LLC; Arsenal Capital Management; Boylston Street Group WIR Staff...
Read More
BioCentury | Nov 4, 2013
Company News

KEW sales and marketing update

...genetic changes in tumors. The company said the test, which was developed and validated in KEW's...
...examine the genetic profile of many common cancers. KEW could not be reached for details. KEW Group Inc....
Read More
BioCentury | Aug 9, 2010
Clinical News

Abraxane nab-paclitaxel regulatory update

...treat metastatic breast cancer after failure of anthracycline therapy. Specialised Therapeutics Australia Pty. Ltd. (East Kew...
Read More
BioCentury | Jul 6, 1999
Company News

EcoScience, Rochester Consulting Group sales and marketing update

...of infecting and killing termites. EcoScience Corp. (ECSCE), East Brunswick, N.J. Rochester Consulting Group , Kew...
Read More
Items per page:
1 - 5 of 5